Search Results for "New Treatment For Hepatitis B"

08:55 EST 24th November 2014 | BioPortfolio

Matching Channels

Hepatitis B

Hepatitis A

Hepatitis C

Most hepatitis C virus (HCV) infected individuals seeking treatment are chronically infected. Treatment goal is to achieve a sustained virological response (SVR), which is the absence of serum HCV R...

Chronic Hepatitis

Hepatitis E virus HEV

Matching News

If Gilead's Hepatitis C Treatment Grosses $10B+ Per Year, Arrowhead's Hepatitis B Treatment Is Attractive.

By David White:In December of 2013, Gilead Sciences (NASDAQ:GILD) started marketing its Hepatitis C treatment Sovaldi in the US. GILD was able to sell $5.75B of Sovaldi in 1H 2014; and the sales were ...

New Report: Innovation in Hepatitis C Treatment

Today, the California Healthcare Institute released a report on the public health impact of Hepatitis C and the potential of groundbreaking new treatments to save tens of thousands of lives over the c...

[Articles] HIV, hepatitis B virus, and hepatitis C virus co-infection in patients in the China National Free Antiretroviral Treatment Program, 2010–12: a retrospective observational cohort study

Screening for viral hepatitis is important in individuals diagnosed as HIV positive. Effective management for viral hepatitis should be integrated into HIV treatment programmes. Long-term data are nee...

Decade in review—HCV: Hepatitis C therapy—a fast and competitive race

The past 10 years have witnessed incredible developments in the treatment of hepatitis C. From an era in which the standard of care was PEG-IFN and ribavirin back in 2004, various interferon-free regi...

Hepatitis B Virus Treatment Beyond the Guidelines

The aim of this review is to clarify how to treat hepatitis B and who should be treated, as well as when to stop treatment. Therapeutic Advances in Gastroenterology

A Home Run for Hepatitis C Treatment

Dr. William Balistreri describes the rapidly evolving landscape of hepatitis C treatment. Medscape Gastroenterology

BMS pulls hep C combo treatment in US

Bristol-Myers Squibb will not attempt to bring its new combination hepatitis C treatment to the US market given the current scale of competition it would face from rival companies. In a statement BMS ...

Hepatitis C Treatment: Hope on the Horizon

Highly effective, tolerable treatment options for hepatitis C offer hope to patients and providers. Medscape Gastroenterology

Matching PubMed Articles

Treatment cessation of entecavir in Asian patients with hepatitis B e antigen negative chronic hepatitis B: a multicentre prospective study.

The off-treatment durability of nucleos(t)ide analogue therapy in Asian hepatitis B e antigen (HBeAg) negative chronic hepatitis B (CHB) and the role of hepatitis B surface antigen (HBsAg) levels in p...

Classical and Modern Approaches Used for Viral Hepatitis Diagnosis.

Viral hepatitis diagnosis is an important issue in the treatment procedure of this infection. Late diagnosis and delayed treatment of viral hepatitis infections can lead to irreversible liver damages ...

Sofosbuvir: First Global Approval.

Sofosbuvir (Solvadi™), a nucleotide analogue hepatitis C virus NS5B polymerase inhibitor, is under development with Gilead Sciences for the once-daily, oral treatment of chronic hepatitis C. Oral so...

The impact of pegylated interferon and ribavirin combination treatment on lipid metabolism and insulin resistance in chronic hepatitis C patients.

Lipid profile and insulin resistance (IR) are associated with hepatitis C virus (HCV) and may predict the chronic hepatitis C (CHC) treatment response. The aim of this study was to determine the assoc...

First-line monotherapies of tenofovir and entecavir have comparable efficacies in hepatitis B treatment.

Hepatitis B virus (HBV) infection is a health problem worldwide. Current treatment options for chronic hepatitis B (CHB) are nucleoside or nucleotide analogues and pegylated interferons. Tenofovir and...

Search Whole site using Google

Search BioPortfolio:
Advertisement Advertisement